Five-Membered Ring Peroxide Selectively Initiates Ferroptosis in Cancer Cells

ACS Chemical Biology

Volumn 11, Issue 5, 2016, Pages 1305-1312

  Abrams, Rachel P ^a,b   Carroll, William L ^b   Woerpel, K A ^a  

^a NEW YORK UNIVERSITY   (United States)

^b NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,2 DIOXOLANE; ARTEMISININ; CARBON OXYGEN MONOCYCLE; DOXORUBICIN; IRON; ORGANIC COMPOUND; PACLITAXEL; PEROXIDE; PLAKINIC ACID; SORAFENIB; UNCLASSIFIED DRUG; VORINOSTAT; ANTINEOPLASTIC AGENT;

APOPTOSIS; ARTICLE; CANCER CELL; CANCER CELL LINE; CELL DEATH; CHEMICAL STRUCTURE; CONTROLLED STUDY; ENANTIOMER; FERROPTOSIS; GROWTH INHIBITION; HUMAN; HUMAN CELL; IN VITRO STUDY; OXIDATIVE STRESS; PRIORITY JOURNAL; RING OPENING; THERMOSTABILITY; CELL LINE; CHEMISTRY; DRUG EFFECTS; METABOLISM; MOLECULAR MODEL; NEOPLASMS; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; CELL DEATH; CELL LINE; CELL LINE, TUMOR; HUMANS; MODELS, MOLECULAR; NEOPLASMS; OXIDATIVE STRESS; PEROXIDES;

EID: 84971278874     PISSN: 15548929     EISSN: 15548937     Source Type: Journal    
DOI: 10.1021/acschembio.5b00900     Document Type: Article

References (69)

1. Siegel, R., Naishadham, D., and Jemal, A. (2013) Cancer Statistics, 2013 Ca-Cancer J. Clin. 63, 11-30 10.3322/caac.21166
2. Siegel, R. L., Miller, K. D., and Jemal, A. (2015) Cancer Statistics, 2015 Ca-Cancer J. Clin. 65, 5-29 10.3322/caac.21254
3. Holohan, C., Van Schaeybroeck, S., Longley, D. B., and Johnston, P. G. (2013) Cancer drug resistance: an evolving paradigm Nat. Rev. Cancer 13, 714-726 10.1038/nrc3599
4. Chonghaile, T. N., Sarosiek, K. A., Vo, T.-T., Ryan, J. A., Tammareddi, A., Moore, V. D. G., Deng, J., Anderson, K. C., Richardson, P., Tai, Y.-T., Mitsiades, C. S., Matulonis, U. A., Drapkin, R., Stone, R., DeAngelo, D. J., McConkey, D. J., Sallan, S. E., Silverman, L., Hirsch, M. S., Carrasco, D. R., and Letai, A. (2011) Pretreatment Mitochondrial Priming Correlates with Clinical Response to Cytotoxic Chemotherapy Science 334, 1129-1133 10.1126/science.1206727
5. Czabotar, P. E., Lessene, G., Strasser, A., and Adams, J. M. (2014) Control of apoptosis by the BCL-2 protein family: implications for physiology and therapy Nat. Rev. Mol. Cell Biol. 15, 49-63 10.1038/nrm3722
6. Gasco, M. and Crook, T. (2003) p53 family members and chemoresistance in cancer: what we know and what we need to know Drug Resist. Updates 6, 323-328 10.1016/j.drup.2003.11.001
7. Bruns, R. F. and Watson, I. A. (2012) Rules for Identifying Potentially Reactive or Promiscuous Compounds J. Med. Chem. 55, 9763-9772 10.1021/jm301008n
8. Baell, J. B. and Holloway, G. A. (2010) New Substructure Filters for Removal of Pan Assay Interference Compounds (PAINS) from Screening Libraries and for Their Exclusion in Bioassays J. Med. Chem. 53, 2719-2740 10.1021/jm901137j
9. Yu, B. and Reynisson, J. (2011) Bond stability of the "undesirable" heteroatom-heteroatom molecular moieties for high-throughput screening libraries Eur. J. Med. Chem. 46, 5833-5837 10.1016/j.ejmech.2011.09.044
10. Guidelines for the Treatment of Malaria (2010), Second ed., World Health Organization, Geneva, Switzerland.
11. Crespo-Ortiz, M. P. and Wei, M. Q. (2012) Antitumor Activity of Artemisinin and Its Derivatives: From a Well-Known Antimalarial Agent to a Potential Anticancer Drug J. Biomed. Biotechnol. 2012, 1-18 10.1155/2012/247597
12. Krishna, S., Ganapathi, S., Ster, I. C., Saeed, M. E. M., Cowan, M., Finlayson, C., Kovacsevics, H., Jansen, H., Kremsner, P. G., Efferth, T., and Kumar, D. (2015) A Randomised, Double Blind, Placebo-Controlled Pilot Study of Oral Artesunate Therapy for Colorectal Cancer EBioMedicine 2, 82-90 10.1016/j.ebiom.2014.11.010
13. Csuk, R., Niesen-Barthel, A., Barthel, A., Kluge, R., and Ströhl, D. (2010) Synthesis of an antitumor active endoperoxide from 11-keto-β-boswellic acid Eur. J. Med. Chem. 45, 3840-3843 10.1016/j.ejmech.2010.05.036
14. Davidson, B. S. (1991) Cytotoxic Five-Membered Cyclic Peroxides from a Plakortis Sponge J. Org. Chem. 56, 6722-6724 10.1021/jo00023a048
15. Stong, R. C., Korsmeyer, S. J., Parkin, J. L., Arthur, D. C., and Kersey, J. H. (1985) Human Acute Leukemia Cell Line With the t(4;11) Chromosomal Rearrangement Exhibits B Lineage and Monocytic Characteristics Blood 65, 21-31
16. Dixon, S. J., Lemberg, K. M., Lamprecht, M. R., Skouta, R., Zaitsev, E. M., Gleason, C. E., Patel, D. N., Bauer, A. J., Cantley, A. M., Yang, W. S., Morrison, B., III, and Stockwell, B. R. (2012) Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death Cell 149, 1060-1072 10.1016/j.cell.2012.03.042
17. Ramirez, A. and Woerpel, K. A. (2005) Synthesis of 1,2-Dioxolanes by Annulation Reactions of Peroxycarbenium Ions with Alkenes Org. Lett. 7, 4617-4620 10.1021/ol051703u
18. Li, Y., Hao, H.-D., Zhang, Q., and Wu, Y. (2009) A Broadly Applicable Mild Method for the Synthesis of gem-Diperoxides from Corresponding Ketones or 1,3-Dioxolanes Org. Lett. 11, 1615-1618 10.1021/ol900262t
19. Yang, W. S., SriRamaratnam, R., Welsch, M. E., Shimada, K., Skouta, R., Viswanathan, V. S., Cheah, J. H., Clemons, P. A., Shamji, A. F., Clish, C. B., Brown, L. M., Girotti, A. W., Cornish, V. W., Schreiber, S. L., and Stockwell, B. R. (2014) Regulation of Ferroptotic Cancer Cell Death by GPX4 Cell 156, 317-331 10.1016/j.cell.2013.12.010
20. Wong, C. C., Cheng, K.-W., and Rigas, B. (2012) Preclinical Predictors of Anticancer Drug Efficacy: Critical Assessment with Emphasis on Whether Nanomolar Potency Should Be Required of Candidate Agents J. Pharmacol. Exp. Ther. 341, 572-578 10.1124/jpet.112.191957
21. Holbeck, S. L., Collins, J. M., and Doroshow, J. H. (2010) Analysis of Food and Drug Administration-Approved Anticancer Agents in the NCI60 Panel of Human Tumor Cell Lines Mol. Cancer Ther. 9, 1451-1460 10.1158/1535-7163.MCT-10-0106
22. Fallahi-Sichani, M., Honarnejad, S., Heiser, L. M., Gray, J. W., and Sorger, P. K. (2013) Metrics other than potency reveal systematic variation in responses to cancer drugs Nat. Chem. Biol. 9, 708-714 10.1038/nchembio.1337
23. Reinhold, W. C., Sunshine, M., Liu, H., Varma, S., Kohn, K. W., Morris, J., Doroshow, J., and Pommier, Y. (2012) CellMiner: A Web-Based Suite of Genomic and Pharmacologic Tools to Explore Transcript and Drug Patterns in the NCI-60 Cell Line Set Cancer Res. 72, 3499-3511 10.1158/0008-5472.CAN-12-1370
24. Hearn, J. M., Romero-Canelón, I., Qamar, B., Liu, Z., Hands-Portman, I., and Sadler, P. J. (2013) Organometallic Iridium(III) Anticancer Complexes with New Mechanisms of Action: NCI-60 Screening, Mitochondrial Targeting, and Apoptosis ACS Chem. Biol. 8, 1335-1343 10.1021/cb400070a
25. Gmeiner, W. H., Reinhold, W. C., and Pommier, Y. (2010) Genome-Wide mRNA and microRNA Profiling of the NCI 60 Cell-Line Screen and Comparison of FdUMP[10] with Fluorouracil, Floxuridine, and Topoisomerase 1 Poisons Mol. Cancer Ther. 9, 3105-3114 10.1158/1535-7163.MCT-10-0674
26. Shankavaram, U., Varma, S., Kane, D., Sunshine, M., Chary, K., Reinhold, W., Pommier, Y., and Weinstein, J. (2009) CellMiner: a relational database and query tool for the NCI-60 cancer cell lines BMC Genomics 10, 277 10.1186/1471-2164-10-277
27. Raj, L., Ide, T., Gurkar, A. U., Foley, M., Schenone, M., Li, X., Tolliday, N. J., Golub, T. R., Carr, S. A., Shamji, A. F., Stern, A. M., Mandinova, A., Schreiber, S. L., and Lee, S. W. (2011) Selective killing of cancer cells by a small molecule targeting the stress response to ROS Nature 475, 231-234 10.1038/nature10167
28. Dolma, S., Lessnick, S. L., Hahn, W. C., and Stockwell, B. R. (2003) Identification of genotype-selective antitumor agents using synthetic lethal chemical screening in engineered human tumor cells Cancer Cell 3, 285-296 10.1016/S1535-6108(03)00050-3
29. Hahn, W. C., Counter, C. M., Lundberg, A. S., Beijersbergen, R. L., Brooks, M. W., and Weinberg, R. A. (1999) Creation of human tumour cells with defined genetic elements Nature 400, 464-468 10.1038/22780
30. Dussault, P. H., Trullinger, T. K., and Cho-Shultz, S. (2000) Chiral Silyl Ketene Acetals from Thioesters: Reaction with Acetals and Peroxyacetals to form 3-Alkoxy- and 3-Peroxyalkanoates Tetrahedron 56, 9213-9220 10.1016/S0040-4020(00)00894-2
31. McConathy, J. and Owens, M. J. (2003) Stereochemistry in Drug Action Prim. Care Companion J. Clin. Psychiatry 5, 70-73 10.4088/PCC.v05n0202
32. O'Neill, P. M., Rawe, S. L., Borstnik, K., Miller, A., Ward, S. A., Bray, P. G., Davies, J., Oh, C. H., and Posner, G. H. (2005) Enantiomeric 1,2,4-Trioxanes Display Equivalent in vitro Antimalarial Activity Versus Plasmodium falciparum Malaria Parasites: Implications for the Molecular Mechanism of Action of the Artemisinins ChemBioChem 6, 2048-2054 10.1002/cbic.200500048
33. Koopman, G., Reutelingsperger, C. P., Kuijten, G. A., Keehnen, R. M., Pals, S. T., and van Oers, M. H. J. (1994) Annexin V for Flow Cytometric Detection of Phosphatidylserine Expression on B Cells Undergoing Apoptosis Blood 84, 1415-1420
34. Riedl, S. J. and Shi, Y. (2004) Molecular Mechanisms of Caspase Regulation during Apoptosis Nat. Rev. Mol. Cell Biol. 5, 897-907 10.1038/nrm1496
35. Kerr, J. F. R., Wyllie, A. H., and Currie, A. R. (1972) Apoptosis: A Basic Biological Phenomenon with Wide-Ranging Implications in Tissue Kinetics Br. J. Cancer 26, 239-257 10.1038/bjc.1972.33
36. Kroemer, G., El-Deiry, W. S., Golstein, P., Peter, M. E., Vaux, D., Vandenabeele, P., Zhivotovsky, B., Blagosklonny, M. V., Malorni, W., Knight, R. A., Piacentini, M., Nagata, S., and Melino, G. (2005) Classification of cell death: recommendations of the Nomenclature Committee on Cell Death Cell Death Differ. 12, 1463-1467 10.1038/sj.cdd.4401724
37. Galluzzi, L., Maiuri, M. C., Vitale, I., Zischka, H., Castedo, M., Zitvogel, L., and Kroemer, G. (2007) Cell death modalities: classification and pathophysiological implications Cell Death Differ. 14, 1237-1243 10.1038/sj.cdd.4402148
38. Rotruck, J. T., Pope, A. L., Ganther, H. E., Swanson, A. B., Hafeman, D. G., and Hoekstra, W. G. (1973) Selenium: Biochemical Role as a Component of Glutathione Peroxidase Science 179, 588-590 10.1126/science.179.4073.588
39. Brigelius-Flohé, R. and Maiorino, M. (2013) Glutathione peroxidases Biochim. Biophys. Acta, Gen. Subj. 1830, 3289-3303 10.1016/j.bbagen.2012.11.020
40. Seiler, A., Schneider, M., Förster, H., Roth, S., Wirth, E. K., Culmsee, C., Plesnila, N., Kremmer, E., Rådmark, O., Wurst, W., Bornkamm, G. W., Schweizer, U., and Conrad, M. (2008) Glutathione Peroxidase 4 Senses and Translates Oxidative Stress into 12/15-Lipoxygenase Dependent- and AIF-Mediated Cell Death Cell Metab. 8, 237-248 10.1016/j.cmet.2008.07.005
41. Friedmann Angeli, J. P., Schneider, M., Proneth, B., Tyurina, Y. Y., Tyurin, V. A., Hammond, V. J., Herbach, N., Aichler, M., Walch, A., Eggenhofer, E., Basavarajappa, D., Rådmark, O., Kobayashi, S., Seibt, T., Beck, H., Neff, F., Esposito, I., Wanke, R., Förster, H., Yefremova, O., Heinrichmeyer, M., Bornkamm, G. W., Geissler, E. K., Thomas, S. B., Stockwell, B. R., O'Donnell, V. B., Kagan, V. E., Schick, J. A., and Conrad, M. (2014) Inactivation of the ferroptosis regulator Gpx4 triggers acute renal failure in mice Nat. Cell Biol. 16, 1180-1191 10.1038/ncb3064
42. Drummen, G. P., van Liebergen, L. C., Op den Kamp, J. A., and Post, J. A. (2002) C11-BODIPY 581/591, an Oxidation-Sensitive Fluorescent Lipid Peroxidation Probe:(micro) Spectroscopic Characterization and Validation of Methodology Free Radical Biol. Med. 33, 473-490 10.1016/S0891-5849(02)00848-1
43. Skouta, R., Dixon, S. J., Wang, J., Dunn, D. E., Orman, M., Shimada, K., Rosenberg, P. A., Lo, D. C., Weinberg, J. M., Linkermann, A., and Stockwell, B. R. (2014) Ferrostatins Inhibit Oxidative Lipid Damage and Cell Death in Diverse Disease Models J. Am. Chem. Soc. 136, 4551-4556 10.1021/ja411006a
44. Lossos, I. S., Czerwinski, D. K., Alizadeh, A. A., Wechser, M. A., Tibshirani, R., Botstein, D., and Levy, R. (2004) Prediction of Survival in Diffuse Large-B-Cell Lymphoma Based on the Expression of Six Genes N. Engl. J. Med. 350, 1828-1837 10.1056/NEJMoa032520
45. Abdel-Fatah, T. M. A., Perry, C., Dickinson, P., Ball, G., Moseley, P., Madhusudan, S., Ellis, I. O., and Chan, S. Y. T. (2013) Bcl2 is an independent prognostic marker of triple negative breast cancer (TNBC) and predicts response to anthracycline combination (ATC) chemotherapy (CT) in adjuvant and neoadjuvant settings Ann. Oncol. 24, 2801-2807 10.1093/annonc/mdt277
46. Oltersdorf, T., Elmore, S. W., Shoemaker, A. R., Armstrong, R. C., Augeri, D. J., Belli, B. A., Bruncko, M., Deckwerth, T. L., Dinges, J., Hajduk, P. J., Joseph, M. K., Kitada, S., Korsmeyer, S. J., Kunzer, A. R., Letai, A., Li, C., Mitten, M. J., Nettesheim, D. G., Ng, S., Nimmer, P. M., O'Connor, J. M., Oleksijew, A., Petros, A. M., Reed, J. C., Shen, W., Tahir, S. K., Thompson, C. B., Tomaselli, K. J., Wang, B., Wendt, M. D., Zhang, H., Fesik, S. W., and Rosenberg, S. H. (2005) An inhibitor of Bcl-2 family proteins induces regression of solid tumours Nature 435, 677-681 10.1038/nature03579
47. Souers, A. J., Leverson, J. D., Boghaert, E. R., Ackler, S. L., Catron, N. D., Chen, J., Dayton, B. D., Ding, H., Enschede, S. H., Fairbrother, W. J., Huang, D. C. S., Hymowitz, S. G., Jin, S., Khaw, S. L., Kovar, P. J., Lam, L. T., Lee, J., Maecker, H. L., Marsh, K. C., Mason, K. D., Mitten, M. J., Nimmer, P. M., Oleksijew, A., Park, C. H., Park, C.-M., Phillips, D. C., Roberts, A. W., Sampath, D., Seymour, J. F., Smith, M. L., Sullivan, G. M., Tahir, S. K., Tse, C., Wendt, M. D., Xiao, Y., Xue, J. C., Zhang, H., Humerickhouse, R. A., Rosenberg, S. H., and Elmore, S. W. (2013) ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets Nat. Med. 19, 202-208 10.1038/nm.3048
48. Konopleva, M., Contractor, R., Tsao, T., Samudio, I., Ruvolo, P. P., Kitada, S., Deng, X., Zhai, D., Shi, Y.-X., Sneed, T., Verhaegen, M., Soengas, M., Ruvolo, V. R., McQueen, T., Schober, W. D., Watt, J. C., Jiffar, T., Ling, X., Marini, F. C., Harris, D., Dietrich, M., Estrov, Z., McCubrey, J., May, W. S., Reed, J. C., and Andreeff, M. (2006) Mechanisms of apoptosis sensitivity and resistance to the BH3 mimetic ABT-737 in acute myeloid leukemia Cancer Cell 10, 375-388 10.1016/j.ccr.2006.10.006
49. Lowe, S. W., Ruley, H. E., Jacks, T., and Housman, D. E. (1993) p53-Dependent Apoptosis Modulates the Cytotoxicity of Anticancer Agents Cell 74, 957-967 10.1016/0092-8674(93)90719-7
50. Weinstein, J. N., Myers, T. G., O'Connor, P. M., Friend, S. H., Fornace, A. J., Kohn, K. W., Fojo, T., Bates, S. E., Rubinstein, L. V., Anderson, N. L., Buolamwini, J. K., van Osdol, W. W., Monks, A. P., Scudiero, D. A., Sausville, E. A., Zaharevitz, D. W., Bunow, B., Viswanadhan, V. N., Johnson, G. S., Wittes, R. E., and Paull, K. D. (1997) An Information-Intensive Approach to the Molecular Pharmacology of Cancer Science 275, 343-349 10.1126/science.275.5298.343
51. Hollstein, M., Sidransky, D., Vogelstein, B., and Harris, C. (1991) p53 Mutations in Human Cancers Science 253, 49-53 10.1126/science.1905840
52. Berglind, H., Pawitan, Y., Kato, S., Ishioka, C., and Soussi, T. (2008) Analysis of p53 mutation status in human cancer cell lines: a paradigm for cell line cross-contamination Cancer Biol. Ther. 7, 699-708 10.4161/cbt.7.5.5712
53. Pinnix, Z. K., Miller, L. D., Wang, W., D'Agostino, R., Kute, T., Willingham, M. C., Hatcher, H., Tesfay, L., Sui, G., Di, X., Torti, S. V., and Torti, F. M. (2010) Ferroportin and Iron Regulation in Breast Cancer Progression and Prognosis Sci. Transl. Med. 2, 43ra56 10.1126/scitranslmed.3001127
54. Yang, W. S. and Stockwell, B. R. (2008) Synthetic Lethal Screening Identifies Compounds Activating Iron-Dependent, Nonapoptotic Cell Death in Oncogenic-RAS-Harboring Cancer Cells Chem. Biol. 15, 234-245 10.1016/j.chembiol.2008.02.010
55. Haeggström, J. Z. and Funk, C. D. (2011) Lipoxygenase and Leukotriene Pathways: Biochemistry, Biology, and Roles in Disease Chem. Rev. 111, 5866-5898 10.1021/cr200246d
56. Shimizu, T. and Wolfe, L. S. (1990) Arachidonic Acid Cascade and Signal Transduction J. Neurochem. 55, 1-15 10.1111/j.1471-4159.1990.tb08813.x
57. Conrad, M., Schneider, M., Seiler, A., and Bornkamm, G. W. (2007) Physiological role of phospholipid hydroperoxide glutathione peroxidase in mammals Biol. Chem. 388, 1019-1025 10.1515/BC.2007.130
58. Jiang, L., Kon, N., Li, T., Wang, S.-J., Su, T., Hibshoosh, H., Baer, R., and Gu, W. (2015) Ferroptosis as a p53-mediated activity during tumour suppression Nature 520, 57-62 10.1038/nature14344
59. Dixon, S. J., Patel, D. N., Welsch, M., Skouta, R., Lee, E. D., Hayano, M., Thomas, A. G., Gleason, C. E., Tatonetti, N. P., Slusher, B. S., and Stockwell, B. R. (2014) Pharmacological inhibition of cystine-glutamate exchange induces endoplasmic reticulum stress and ferroptosis, eLife 3, DOI: 10.7554/eLife.02523.
60. Ooko, E., Saeed, M. E. M., Kadioglu, O., Sarvi, S., Colak, M., Elmasaoudi, K., Janah, R., Greten, H. J., and Efferth, T. (2015) Artemisinin derivatives induce iron-dependent cell death (ferroptosis) in tumor cells Phytomedicine 22, 1045-1054 10.1016/j.phymed.2015.08.002
61. Eling, N., Reuter, L., Hazin, J., Hamacher-Brady, A., and Brady, N. R. (2015) Identification of artesunate as a specific activator of ferroptosis in pancreatic cancer cells Oncoscience 2, 517-532 10.18632/oncoscience.160
62. Hamacher-Brady, A., Stein, H. A., Turschner, S., Toegel, I., Mora, R., Jennewein, N., Efferth, T., Eils, R., and Brady, N. R. (2011) Artesunate Activates Mitochondrial Apoptosis in Breast Cancer Cells via Iron-catalyzed Lysosomal Reactive Oxygen Species Production J. Biol. Chem. 286, 6587-6601 10.1074/jbc.M110.210047
63. Dixon, S. J. and Stockwell, B. R. (2014) The role of iron and reactive oxygen species in cell death Nat. Chem. Biol. 10, 9-17 10.1038/nchembio.1416
64. Mercer, A. E., Maggs, J. L., Sun, X.-M., Cohen, G. M., Chadwick, J., O'Neill, P. M., and Park, B. K. (2007) Evidence for the Involvement of Carbon-centered Radicals in the Induction of Apoptotic Cell Death by Artemisinin Compounds J. Biol. Chem. 282, 9372-9382 10.1074/jbc.M610375200
65. Lu, J.-J., Meng, L.-H., Cai, Y.-J., Chen, Q., Tong, L.-J., Lin, L.-P., and Ding, J. (2008) Dihydroartemisinin induces apoptosis in HL-60 leukemia cells dependent of iron and p38 mitogen-activated protein kinase activation but independent of reactive oxygen species Cancer Biol. Ther. 7, 1017-1023 10.4161/cbt.7.7.6035
66. Gao, W., Xiao, F., Wang, X., and Chen, T. (2013) Artemisinin induces A549 cell apoptosis dominantly via a reactive oxygen species-mediated amplification activation loop among caspase-9, -8 and -3 Apoptosis 18, 1201-1213 10.1007/s10495-013-0857-z
67. Berdelle, N., Nikolova, T., Quiros, S., Efferth, T., and Kaina, B. (2011) Artesunate Induces Oxidative DNA Damage, Sustained DNA Double-Strand Breaks, and the ATM/ATR Damage Response in Cancer Cells Mol. Cancer Ther. 10, 2224-2233 10.1158/1535-7163.MCT-11-0534
68. Chen, H., Sun, B., Wang, S., Pan, S., Gao, Y., Bai, X., and Xue, D. (2010) Growth inhibitory effects of dihydroartemisinin on pancreatic cancer cells: involvement of cell cycle arrest and inactivation of nuclear factor-κB J. Cancer Res. Clin. Oncol. 136, 897-903 10.1007/s00432-009-0731-0
69. Martyn, D. C., Ramirez, A. P., Beattie, M. J., Cortese, J. F., Patel, V., Rush, M. A., Woerpel, K. A., and Clardy, J. (2008) Synthesis of spiro-1,2-dioxolanes and their activity against Plasmodium falciparum Bioorg. Med. Chem. Lett. 18, 6521-6524 10.1016/j.bmcl.2008.10.083